Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?

Ozsoy, Zehra; Ozdemir, Adem; Ekici, Mustafa; Bilgin, Emre; Kilic, Levent; Kiraz, Sedat; Saribas, Zeynep; Sener, Burçin; Karadag, Omer

Ozsoy, Zehra; Ozdemir, Adem; Ekici, Mustafa; Bilgin, Emre; Kilic, Levent; Kiraz, Sedat; Saribas, Zeynep; Sener, Burçin; Karadag, Omer.

Afiliación

Ozsoy Z; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey. dr.zehraduman@hotmail.com.
Ozdemir A; Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Ekici M; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Bilgin E; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Kilic L; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Kiraz S; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Saribas Z; Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Sener B; Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Karadag O; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Rheumatol Int ; 43(8): 1445-1451, 2023 08.

Article en En | MEDLINE | ID: mdl-37005937

Asunto(s)

Antirreumáticos; Artritis Reumatoide; Productos Biológicos; Tuberculosis Latente; Tuberculosis; Humanos; Tuberculosis/tratamiento farmacológico; Ensayos de Liberación de Interferón gamma/métodos; Tuberculosis Latente/tratamiento farmacológico; Artritis Reumatoide/tratamiento farmacológico; Antirreumáticos/uso terapéutico; Inmunosupresores/uso terapéutico; Productos Biológicos/uso terapéutico; Prueba de Tuberculina/métodos

Palabras clave

Biologic/targeted-synthetic disease modifying anti-rheumatismal drugs; Immunosuppressive drugs; Interferon-gamma release assays; Latent tuberculosis reactivation; QuantiFERON-TB Gold Plus; Rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Reumatoide / Tuberculosis / Productos Biológicos / Antirreumáticos / Tuberculosis Latente Límite: Humans Idioma: En Revista: Rheumatol Int Año: 2023 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google